Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Millar

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Visualized Experiments : Jove|February 15, 2018
Routine Screening Method for Microparticles in Platelet TransfusionsDaniel Millar, Larry Murphy, Audrey Labrie, et al.
Transfusion|September 1, 2018
Screening of red blood cells for extracellular vesicle content as a product quality indicatorJason P Acker, Ruqayyah J Almizraq, Daniel Millar, et al.
Clinical Trials (London, England)|September 10, 2022
Mobilizing the clinical trial ecosystem to drive adoption of master protocolsAbby Bronson, Marianne K Chase, Kimberly Fisher, et al.
Eclinicalmedicine|January 16, 2024
Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARLFranz Koenig, Cécile Spiertz, Daniel Millar, et al.
The Pediatric Infectious Disease Journal|November 4, 2010
Oral ivermectin for treatment of pediculosis capitisMahreen Ameen, Roberto Arenas, Janeth Villanueva-Reyes, et al.
Transfusion|July 31, 2020
Comparison of the platelet activation status of single-donor platelets obtained with two different cell separator technologiesDaniel Millar, Chelsea Hayes, Jessica Jones, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Visualized Experiments : Jove|February 15, 2018
Routine Screening Method for Microparticles in Platelet TransfusionsDaniel Millar, Larry Murphy, Audrey Labrie, et al.
Transfusion|September 1, 2018
Screening of red blood cells for extracellular vesicle content as a product quality indicatorJason P Acker, Ruqayyah J Almizraq, Daniel Millar, et al.
Clinical Trials (London, England)|September 10, 2022
Mobilizing the clinical trial ecosystem to drive adoption of master protocolsAbby Bronson, Marianne K Chase, Kimberly Fisher, et al.
Eclinicalmedicine|January 16, 2024
Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARLFranz Koenig, Cécile Spiertz, Daniel Millar, et al.
The Pediatric Infectious Disease Journal|November 4, 2010
Oral ivermectin for treatment of pediculosis capitisMahreen Ameen, Roberto Arenas, Janeth Villanueva-Reyes, et al.
Transfusion|July 31, 2020
Comparison of the platelet activation status of single-donor platelets obtained with two different cell separator technologiesDaniel Millar, Chelsea Hayes, Jessica Jones, et al.
Pageof 1